As I mentioned in a previous post , I presented at this year's Health 2.0. I also stayed for a number of sessions on digital and innovation. As a relative newcomer to this industry it was enlightening to hear the common themes coming through in presentations from the big pharma companies, so I thought I'd share my main takeaways. The strategic direction of the industry can seemingly be summed up in the phrase "beyond the pill", which is a composite of two big ideas: Digital-only treatments that address the root cause of health problems, which are often bio-psycho-social. Lifestyle, not disease is killing people, so it may be possible to create highly addictive, game-like experiences that change lifestyles and therefore beat the statistics. Treatment ecosystems that reflect the fact that people's problems are often blends of ailments that cannot be effectively treated by a single drug provider or physician. Doing this for real suggests some kind of aggregato...
Thoughts on strategy in a Digital Economy